TY - JOUR
T1 - Iatrogenic immunosuppression and cutaneous malignancy
AU - DePry, Jennifer L.
AU - Reed, Kurtis B.
AU - Cook-Norris, Robert H.
AU - Brewer, Jerry D.
PY - 2011/11
Y1 - 2011/11
N2 - Patients with autoimmune and inflammatory conditions often receive long-term immunosuppressive therapy. Some of the largest patient populations with iatrogenic immunosuppression include patients who have received solid-organ transplants or who have rheumatoid arthritis or psoriasis. Although treatments improve patient outcomes, individuals with immunosuppression subsequently may have an increased risk of skin cancer, including squamous cell carcinoma, basal cell carcinoma, and malignant melanoma.
AB - Patients with autoimmune and inflammatory conditions often receive long-term immunosuppressive therapy. Some of the largest patient populations with iatrogenic immunosuppression include patients who have received solid-organ transplants or who have rheumatoid arthritis or psoriasis. Although treatments improve patient outcomes, individuals with immunosuppression subsequently may have an increased risk of skin cancer, including squamous cell carcinoma, basal cell carcinoma, and malignant melanoma.
UR - http://www.scopus.com/inward/record.url?scp=80054736623&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=80054736623&partnerID=8YFLogxK
U2 - 10.1016/j.clindermatol.2011.08.009
DO - 10.1016/j.clindermatol.2011.08.009
M3 - Comment/debate
C2 - 22014982
AN - SCOPUS:80054736623
SN - 0738-081X
VL - 29
SP - 602
EP - 613
JO - Clinics in Dermatology
JF - Clinics in Dermatology
IS - 6
ER -